Class IA phosphotidylinositol-3-kinases (PI3Ks) are a family of p85/p110 heterodimeric lipid kinases that are important in regulating signaling events in B and T cells. However, their role in natural killer (NK) cells is not understood. Here, using mice that lack the regulatory p85a subunit and its alternatively spliced variants p55a/p50a (collectively termed as p85a
Introduction
Natural killer (NK) cells are critical mediators of innate immunity that defend against many viral or bacterial infections as well as tumor growth. 1 NK cells are granular, bone marrow (BM)-derived lymphocytes capable of executing 'natural cytotoxicity' of target cells without prior sensitizations. 2 NK cells bridge innate and adaptive immune responses through the secretion of a variety of cytokines and chemokines. Effector functions of NK cells are regulated by the coordinated interaction of activating and inhibitory receptors. 1 NK cells use multiple nonpolymorphic activating receptors such as NKG2D, NK1.1, FcRgIII, Ly49D, Ly49H and NCRs. 3 NKG2D, is a type-II lectin expressed on all human and murine NK cells and it recognizes MIC-A/B 4 and ULBP-1/2/3 5 in human; H60, 6, 7 Rae-1a/b/g/d/e 7 and Mult-1 8 in mouse. NKG2D employs Src family protein tyrosine kinases (PTKs) to initiate two distinct signaling pathways. In the first pathway, activated PTK phosphorylates DAP10 at Tyr-Ile-Asn-Met (YINM) motif, which in turn recruits PI3K-p85. 9 In the second pathway, the Src family PTKs phosphorylates DAP12 in the immunoreceptor tyrosine-based activation motif, which subsequently triggers Syk and ZAP70. [10] [11] [12] [13] Lack of DAP10, DAP12 or Syk/ZAP70 13 do not significantly affect the NKG2D-mediated cytotoxicity. This suggests that DAP10-PI3K-p85 and DAP12-Syk/ZAP70 pathways are redundant in mediating cytotoxicity. However, lack of DAP12 or Syk/ZAP70, but not DAP10, severely impairs NKG2D-mediated cytokine production. 12 This indicates an exclusive role for the DAP12-Syk/ZAP70 pathway in cytokine generation. NK1.1 (Nkrp1c) is a unique cell marker expressed on NK and NKT cells. 14 Although the activating ligands for Nkrp1c have yet to be determined, the inhibitory ligands for its related family members Nkrp1d and Nkrp1f have been defined as the Clr family of C-type lectins. 15 NK1.1 physically associates with FcRg to mediate its signal. 16 The interplay between the activating and inhibitory receptors regulates NK cell functions. Murine NK inhibitory receptors such as Ly49A, Ly49C, Ly49G2 and Ly49I recognize classical major histocompatibility complex (MHC) class I molecules. 17 Upon recognition, they recruit phosphatases to the immunoreceptor tyrosinebased inhibitory motif in their cytoplasmic domains. 18 Thus, NK cells use a complex set of receptors and signaling pathways to achieve their intended effector functions.
Although it is well established that NKG2D/DAP10 complexes recruit p85, the specific isoform that is used and its precise downstream functions are not known. Class 1A phosphotidylinositol-3-kinases (PI3Ks) are a family of p85/p110 heterodimeric lipid kinases that generate critical second messengers downstream of T-and B-cell antigen receptors. [19] [20] [21] PI3K-p85a gene gives rise to two other alternatively spliced isoforms, p55a and p50a, which also participate in p85a-mediated signaling. p85a is a ubiquitously expressed subunit, which binds to one of the p110 catalytic isoforms (p110a, p110b or p110d). 22 The p110a and p110b are also ubiquitously expressed, whereas the p110d is predominantly expressed in hematopoietic cells. 23 PI3K binds to lipid substrates in the membrane and generates PIP 2 and PIP 3 that interact with pleckstrin homology (PH) domain containing proteins. Akt, PDK1 and Btk are the major downstream signaling molecules of PI3K signalosomes. [24] [25] [26] Most of the mice deficient of p85a, p55a and p50a die at birth. 20 In this study, we investigated the role of p85a/p55a/ p50a subunits in NK cells. We show that these isoforms are highly expressed in both freshly isolated and interleukin (IL)-2-cultured NK cells. p85a gene deficiency caused a number of defects in NK cells. Specifically, lack of p85a reduced the lineage commitment of BM-derived progenitors into NK cells. In the absence of p85a, percentages of Ly49A þ , Ly49D 
NK cells exhibited reduced NKG2D-mediated cytotoxicity compared to that of wild type (WT). Cytotoxic potential of p85a
À/À NK cells against RMA/S cells was also significantly reduced. Particularly, p85a À/À NK cells had severely impaired NKG2D and NK1.1-mediated cytokine and chemokine generation. These data, for the first time, provide important insights into the role of p85a/p55a/p50a in the development and functions of NK cells.
Results

Generation of p85a
-/-NK cells PI3K-p85a
-/-mice were generated by deleting the last five exons that are common to p85a, p55a and p50a subunits, in which the last exon also includes the putative polyadenylation signal. 20 Mice deficient for these three regulatory subunits exhibit a high degree of perinatal lethality. 20 Therefore, we generated chimeric mice by transplanting fetal liver cells from 13-to 14-dayold p85a -/-embryos into 4-to 6-week-old, sublethally irradiated NK-null JAK3 -/-mice 27 ( Figure 1a p85a, p55a and p50a are highly expressed in NK cells Regulatory p85a along with the catalytic p110d subunit is important in the development and functions of T and B cells. [19] [20] [21] Deletion of p85a/p55a/p50a severely impaired the functions of these immune cells. To assess its potential role in NK cells, we first examined its protein expression. NK cells were prepared and used on day 6 or 7 of IL-2 culture throughout this study. NK purity was Figure 1 Transfer of p85a -/-fetal liver cells into JAK3 -/-recipients results in the generation of p85a -/-natural killer (NK) cells. (a) p85a -/-mice deficient for all three p85a/p55a/p50a regulatory subunits exhibit a high degree of perinatal lethality with very few animals surviving beyond 1 week of age. Therefore, we generated chimeric mice by transplanting fetal liver cells from 13-to 14-day-old p85a -/-embryos into sublethally irradiated NK-null JAK3 -/-mice. Irradiated JAK3 -/-recipients (300 rad) received 2 Â 10 6 nucleated fetal liver cells from wild type (WT) or p85a -/-through retro-orbital injections. After 2 months, development and functions of NK cells generated from bone marrow, spleen and liver of the transplanted mice were examined. (b-i) p85a/p55a/p50a subunits were absent in p85a -/-, but were abundantly expressed in WT NK cells. Interleukin (IL)-2-cultured NK cells were harvested on day 6, lysed and used for western blot analyses. (b-ii) Sorted fresh T, B and NK or (b-iii) 24 h lipopolysaccharide (LPS)-stimulated T or B and IL-2-activated sixth day NK cells from WT mice express abundant p85a, p55a and p50a proteins. Blots were probed with anti-p85a antibody, stripped and reprobed with anti-actin monoclonal antibodies (mAb) as loading control.
p85a regulates cytokine generation in NK cells A Awasthi et al tested with anti-CD3 and -NK1.1 monoclonal antibodies (mAbs) (Supplementary Figure 1) . Cell lysates from IL-2-activated NK cells indicated the absence of all three subunits in the p85a À/À compared to the WT (Figure 1b-i ). Fresh T, B and NK cells were purified through cell sorting from the spleens of WT mice. Cell lysates were analyzed by western blotting, which demonstrated that p85a and its splice variants p55a/p50a were abundantly expressed in fresh NK cells (Figure 1b-ii) . Expression levels of these subunits in WT NK cells were comparable to that of T and B cells. Expression of p85a/p55a/p50a in IL-2-activated WT NK cells was readily detectable and comparable to lipopolysaccharide (LPS)-activated T and B cells (Figure 1b-iii) .
NK cell number is reduced in the BM and liver of p85a À/À mice Role of p85a deficiency on NK cell development was investigated by analyzing cell-surface markers. 28 The total number of lymphocytes in the BM, spleen and liver were comparable between WT and p85a À/À mice as previously reported 20 (data not shown). Lymphocytes were divided into T (CD3 ; Figure 2a ). These results demonstrate that JAK3 -/-environment can support the development of NK cells from the fetal liver of p85a À/À mice. However, the commitment and maturation of NK cells in the BM are partially dependent on p85a/ p55a/p50a subunits.
Early commitment of HSCs into CD3
À immature NKPs in the BM requires p85a Depending on the expression of different cell-surface markers, NK development in the BM can be defined into five distinct stages. 31 In the first stage of NK development, commitment of hematopoietic stem cells (HSCs) into NK precursors (NKPs) occur by the expression of IL-2/IL-15 receptor b chain, CD122. 
CD122
þ immature NKPs are the earliest known progenitors committed to become NK cells, defined by the absence of mature markers such as NK1.1, NKG2D, NKG2A/C/E, Ly49, CD49b and CD11b. 31, 33 Our results show that the lack of p85a resulted in the reduction of CD3
CD49b
À progenitors in the BM and spleen. Similar reductions were also observed in (Figures 2c and d) . On the basis of these results, we conclude that normal commitment of HSCs into immature CD3
À
CD122
þ progenitors depends on p85a.
Lack of p85a reduces the total number of mature NK cells but does not affect the acquisition of NKG2D, NKG2A/C/E and CD51 receptors Our results demonstrate that the functions of p85a are partially required for the commitment of HSCs into early CD3 À CD122 þ NKPs. To determine the role of p85a for further NK cell development, we analyzed the expression of additional markers on fresh NK. Gated CD3 À NK1.1 þ cells were analyzed for the expression of CD122, NKG2D, NKG2A/C/E and CD51. Acquisition of these markers occurs at the second stage of NK development (Figures 3a and b) . Our results show that the expression of these receptors between p85a À/À and WT NK cells were comparable (Figures 3a and b) . On the basis of these, we conclude that there are defects in the early stage of NK development in p85a À/À mice. However, once they become CD122 positive, they can proceed through the second stage by successfully acquiring NK1.1, NKG2D, NKG2A/C/E and CD51.
Lack of p85a impairs the Ly49 subset specification and CD43 acquisition Acquisition of Ly49 receptors by CD3
þ NK cells marks the third developmental stage. Expression of distinct Ly49 receptors establish a 'repertoire' of NK cell subsets. 34, 35 However, the molecular events that regulate Ly49 gene transcriptions are far from understood. Murine Ly49 receptors can be activating (Ly49D and Ly49H) or inhibiting (Ly49A, Ly49C, Ly49I and Ly49G2). Ly49 receptors recognize MHC class I molecules as their physiological ligands. Expression of one or more inhibitory Ly49 receptors is a key step by which the developing NK cells achieve full functional competency. 36, 37 Our preliminary ex vivo analyses of fresh BM-derived NK cells revealed a significant reduction of 
NKG2D-mediated recognition of 'induced-self' is impaired in p85a
À/À NK cells Expression of ligands for NKG2D receptor are induced by cellular stress. 38 Recognition of these ligands by NK cells leads to target cell lysis. Upon ligand binding, NKG2D/DAP10 complex recruits the p85 subunit. 9 To determine its specific role, we evaluated the ability of p85a À/À NK cells to mediate cytotoxicity. We used EL4 cell lines stably expressing H60 (EL4 H60 ) as a model of induced-self. IL-2-activated p85a À/À NK cells were significantly impaired in their ability to lyze EL4 
CD122
þ cell numbers are not altered in p85a À/À compared to WT mice. BM and spleen cells were stained for CD3e and CD122 markers and the CD3 À CD122 þ cell percentages were enumerated. Data presented are the averages of three independent analyses with standard deviation. 
þ cells and separated for NK1.1 þ and NK1.1 À populations to differentiate between immature and committed NKPs. These subpopulations were further divided based on their CD49b or NKG2A/C/E positivity. Immature NKPs were defined either by CD3 Figure 2) . These results further imply that a complete compensatory effect from the NKG2D/DAP12 complexes did not occur in p85a À/À NK cells and that PI3K may be playing a more significant role than predicted. Recognition of 'missing-self' is severely impaired in p85a À/À NK cells Cells that lack or have reduced expression of self MHC class I molecules are susceptible to NK-mediated cytotoxicity. 39 The lack of engagement by the inhibitory Ly49 receptors to respective MHC class I relieves the NK cells from inhibition. However, the signaling events that positively regulate this cytotoxicity are not fully understood. To test whether p85a is involved in missing-self recognition, we measured the cytotoxic potential of IL-2-activated NK cells against RMA/S tumor cell. Figure 5d demonstrates that the ability of p85a À/À NK cells were about eightfold reduced compared to the WT in mediating this cytotoxicity (a reduction of 73% at 20:1 E:T Ratio). Thus, we conclude that although missing-self recognition does not require activation by NKG2D/ DAP10 complexes, p85a is required for this effector function. The exact molecular mechanism and the receptor-ligand interactions that utilize p85a in this process need to be investigated.
To further confirm the role of p85a in NK-mediated cytotoxicity, we used pharmacological agents Wortmannin and Piceatannol, which inhibit PI3K and Syk, respectively. These inhibitors were chosen because NKG2D/DAP10/PI3K pathway is primarily thought to be responsible for cytotoxicity, whereas NKG2D/ DAP12/Syk pathway can mediate both cytokine gene transcription and cytotoxicity. Wortmannin is known to block all isoforms of PI3K. 40 Earlier studies have shown that the cytotoxicity mediated by NKG2D/DAP10/PI3K pathway can be blocked by Wortmannin. 41, 42 IL-2-cultured WT NK cells were preincubated with varying concentrations of inhibitors, washed and used in cytotoxicity. Treatment with Wortmannin resulted in a significant reduction in the ability of NK cells to mediate cytotoxicity against EL4 H60 in a dose-dependent manner (Figure 5e ). However, only at the highest concentration (100 mM), Piceatannol could inhibit the lysis of EL4 H60 . Wortmannin and Piceatannol together inhibited the cytotoxicity in a dose-dependent manner, similar to that of Wortmannin alone (Figure 5e ). Thus, our observations with p85a À/À NK cells and Wortmannin treatment of WT NK cells demonstrate that p85a is important in regulating NK-mediated cytotoxicity.
Lack of p85a significantly impairs NK-mediated cytokine and chemokine generation Signaling events that initiate the gene transcription of inflammatory cytokines and chemokines in NK cells are not well understood. Therefore, we analyzed the role of p85a in the generation of cytokines and chemokines. IL-2-cultured NK cells on day 6 were treated with titrated concentrations of plate-bound anti-NKG2D (A10) or -NK1.1 (PK136) mAbs. Supernatants were collected and the levels of interferon (IFN)-g and granulocyte-macrophage colony-stimulating factor (GM-CSF) were measured by enzyme-linked immunosorbent assay (ELISA). WT NK cells produced significant amounts of IFN-g and GM-CSF, in a dose-dependent manner. In contrast, p85a À/À NK cells were significantly impaired in their ability to produce IFN-g and GM-CSF (Figures 6a and b) . Further, generation of chemokines such as MIP-1a and MIP-1b 28 However, activation of p85a À/À NK cells with PMA and Iono, either individually or in combinations did not rescue the generation of IFN-g (Supplementary Figure 3) . This indicates that further studies are required to determine the additional defects in p85a À/À NK cells. One possibility is that rather than downstream of PI3K, PMA (or protein kinase C, PKC) could uniquely function upstream for the activation of Src family kinases that are needed to phosphorylate p85a. 43 To assess whether cell death was involved, we stimulated the NK cells with anti-NKG2D mAb for 16 h and analyzed the viability with anti-Annexin-V mAb and a fluorescent DNA stain, 7-amino actinomycin-D (7-AAD). We did not observe any significant differences in the staining of either Annexin-V or 7-AAD between activated WT and p85a À/À NK cells (data not shown). Therefore, we conclude that the activation-induced cell death is not a probable cause for the lower level of cytokine generation in p85a À/À NK cells. Next, we analyzed the ability of the inhibitors in cytokine generation. Wortmannin blocked the generation of both IFN-g and GM-CSF (Figure 6d ). Even at a lower concentration, the level of inhibition on cytokine generation was significantly high (Po0.005). Conversely, only at a higher concentration (50 mM), Piceatannol inhibited the cytokine generation. Both the inhibitors together significantly reduced the generation of IFN-g and GM-CSF (Po0.005; Figure 6d ). Analyses of NK cells after inhibitor treatment did not reveal significant cell death, indicating that any toxic effects of these drugs did not account for our observations (Supplementary Figure 4) . Taken together, our results demonstrate that p85a plays a critical and nonredundant role in cytokine and chemokine generation.
Discussion
In this study, we show p85a is important in regulating NK-mediated effector functions. Alternative splicing of p85a messages generate p55a and p50a proteins that also participate in p85a-mediated signaling. The essential tasks of p85a in T-and B-cell development and function have been extensively characterized. [19] [20] [21] Using p85a
À/À mice, we demonstrate that p85a, p55a and p50a are crucial for NK cell lineage commitment, terminal maturation, cytokine/chemokine generation and cytotoxicity. In recent years, multiple p85 and p110 gene knockout mice have been generated to understand the functions of PI3K complexes. 20, [44] [45] [46] Compared to p85a À/À mice used in our study, a different p85a-deficient mice was generated by disrupting the first exon. This resulted in the exclusive deletion of p85a but not p55a and p50a proteins, which helped the mice to survive. 21 Moreover, NK cell development in these p85a-only deficient mice were unaffected. 21 Thus, the presence of p55a and p50a splice variants can rescue multiple cellular functions in the absence of p85a subunit. The mice used in the present study were generated by removing the last five exons of the p85a gene, resulting in the loss of p85a, p55a and p50a isoforms. 20 As these mice deficient for all three regulatory subunits die perinatally, 20 we generated chimeric mice by transplanting fetal liver cells from 14-day-old p85a -/-embryos into sublethally irradiated NK-null JAK3 -/-mice. 27 Class 1A PI3Ks are heterodimeric proteins made up of regulatory and catalytic subunits. Five regulatory class 1A subunits have been defined and they are p85a, p55a, p50a, p85b and p55g. 23 Each of these regulatory subunits has the ability to associate with any of the three catalytic subunits, p110a, p110b and p110d. 23 Upon receptormediated activation, p85/p110 complexes are recruited to 'YINM' motif containing proteins such as DAP10, CD28, CD19, BCAP, Gab and insulin receptor substrate-IRS. 47 Membrane-recruited PI3K complexes phosphorylate PIP 2 at D3 position to generate PIP 3 . A multitude of proteins with PH domains are activated by PIP 3 , thereby regulating several critical signaling pathways.
Our results demonstrate WT NK cells abundantly express p85a, p55a and p50a and as expected, p85a À/À NK cells lacked all three subunits. One of the major defects due to the lack of p85a is a severe reduction in the NK cell number in the BM and liver. Multiple defects at distinct developmental stages of NK cells can account for this reduction. First, we analyzed the status of early progenitors that are generated from HSCs. In general, the development of NK cells in the BM is divided into five distinct stages. 31 Early lymphoid precursors (ELPs) that give rise to T, B and NK cells have been found in the BM. 48 First stage of NK cell development is defined by generation of NKPs from multipotent HSCs and ELPs. NKPs exclusively mature into NK cells and their presence in the adult BM and fetal thymus have been confirmed. 32 This earliest developmental stage of NKPs is defined by the expression of IL-2/IL-15 receptor-b chain, CD122.
32
Both IL-2 and IL-15 cytokines are important in the development and maturation of NK cells. 49 Also, expression of CD122 by early progenitors uniquely marks the committed NKPs. 33 Both the initiation of CD122 expression and its level in p85a À/À NK cells were not affected, indicating that p85a is dispensable for this developmental step. Also, percentages of CD3
þ cells were not altered in p85a À/À mice. However, it is important to note that the total CD3 À CD122 þ cells include both NK and NKT cells, consisting of different maturation status. Therefore, to determine developmental defects in the early progenitors, we analyzed one specific subset of CD3 À CD122 þ cells that have yet to acquire NK1.1, NKG2A/C/E or CD49b. Our results showed the CD3
À progenitors were considerably reduced in the BM of p85a À/À mice. We conclude that one of the major reasons for the reduction in the mature NK cell number in p85a À/À mice is due to a decrease in the commitment of early progenitors.
Mechanistically, as the PI3K/Akt pathway is important in cell survival, 50 lack of p85a could have rendered the NKPs more susceptible to proapoptotic cell death. As well, a partial blockade of HSCs committing to become NKPs cannot be ruled out. In addition, recent studies have shown that activation and proliferation of certain CD8 þ T cells by IL-15 through CD122 require PI3K/Akt pathway. 51 Analogous to this, lack of p85a could have resulted in a reduced proliferative rate of CD3
Present observations with p85a
À/À mice are distinct compared to our previous studies using PLCg2 À/À mice, where we saw a twofold increase in the numbers of p85a regulates cytokine generation in NK cells 28 This indicates that p85a and PLCg2 may be involved in the commitment of early NK progenitors.
In the second stage of development, CD122 þ NKPs acquire NKG2D, NK1.1 NKG2A/C/E and CD51 in a sequential developmental process. 31 Our results show that NK cells from both p85a À/À and WT expressed comparable levels of these receptors. Therefore, we conclude that the p85a does not play any obligatory role at this stage of NK development.
Ly49 subset specification occurs in the third developmental stage. Here, the 'immature' NKPs start acquiring different Ly49 receptors, whose expression determines the specific repertoire of NK subsets. 32 Analyses of Ly49 expression on p85a À/À NK cells indicated an exclusive reduction in Ly49A, Ly49G2 and Ly49D subsets. Other NK subsets such as Ly49C and Ly49I were unchanged. These reductions can be either due to an early NK cell developmental defect, owing to the absence of p85a or because of a missing regulation of Ly49 expressions by functional PI3K complexes. The p85a À/À mice used in this study was backcrossed to C57BL/6 for seven generations and are of H-2 b haplotype, thereby excluding any strain background effects on these observations. Our previous studies using PLCg2 À/À mice demonstrated a significant reduction in all the Ly49 þ NK subsets, irrespective of their MHC class I ligand preferences. 28 This observation along with our present study indicates that both PLCg2 and p85a are important for subset specifications. Both PLCg2 and PI3K are known to regulate a number of transcription factors. However, their role in regulating transcription factors such as T-bet, 52 GATA-3, 53 IFNregulatory factor-1, 54 IRF-2, 55 ID2, 56 Ets-1, 57 MEF 58 and PU-1 59 that are involved in NK cell development and maturation has yet to be elucidated. Indeed, earlier studies from Di Santo laboratory have shown that lack of GATA-3 reduces the levels of Ly49A, Ly49C/I and Ly49D NK subsets, whereas Ly49G2 and NKG2A/CD94 were unaffected. 53 Thus, a lack of transcription factors such as GATA-3 could partially explain the reduction in Ly49 subsets in p85a À/À mice. Also, PI3K may regulate the expression of these Ly49 receptors after subset specification. ITIM motifs that are located in the cytoplasmic domains of inhibitory Ly49 receptors recruit protein phosphatases such as SHP1, SHP2. 60 These phosphatases regulate the activation pathways by dephosphorylating substrates and are expected to be part of the activation complexes. Therefore, a reduction in Ly49 levels may indicate that p85a is a key player in the dynamic interaction between DAP10/ PI3K complexes, its second messengers and inhibitory Ly49 receptors bound to phosphatases. Evidence for such a relationship has been recently documented in NKT cells. Gene deletion of lipid phosphatase, PTEN, whose major substrate is PIP 3 , leads to an increased Ly49C and Ly49I expression in NKT cells. 61 Interestingly, this abnormal increase can be reversed by backcrossing the PTEN À/À mice with p110d D910A/D910A mice. 61 Thus, it is possible that PI3K regulates the Ly49 expression to provide a signaling balance and to prevent activation of NK against 'self' targets.
Fourth stage of NK cell development is defined by a concomitant reduction in CD51, an increase in CD49b expression and an augmented proliferation. 31 Lack of p85a did not alter these expected phenotypic changes.
In the fifth and final developmental stage, NK cells increase the levels of CD11b and CD43. 31, 32 This terminal maturation is an essential step for the NK cells to achieve full functional competency. NK cells from p85a À/À mice expressed significantly lower levels of CD43 compared to that of WT, whereas the expression of CD11b was unaffected. CD43 is a highly glycosylated, transmembrane mucin expressed in all hematopoietic cells except resting B cells and erythrocytes. 62 Galectin-1 is one of the natural ligands for CD43. 63 Why is the expression level of CD43 affected in p85a À/À NK cells? Recent studies show CD43 contains a putative SH3 domain-binding site and through this it can interact with Fyn kinase. 64 Fyn is also one of the major Src family members that phosphorylates and activates p85a. A synthetic peptide derived from the SH3 domain-binding site of p85a completely blocked the interaction between CD43 and Fyn, indicating that both CD43 and p85a compete for Fyn. 64 These studies indicate that CD43 can regulate receptor-mediated activation by direct physical inhibition of p85a. On the basis of these, we predict the existence of a counterbalance that regulates the expression and function of CD43 by p85a. A similar CD43 reduction in T-bet À/À splenocytes 52 provides another molecular explanation, where T-bet could be one of the target transcription factors downstream of p85a. Collectively, our observations set the stage for a detailed analysis that would determine the exact cause for the CD43 reduction. Natural cytotoxicity mediated by NK cells can kill tumor cells without prior sensitization. Significant reduction observed in p85a À/À NK recognition of induced-self and missing-self demonstrate p85a is important in NK cytotoxicity. Murine NKG2D associates with DAP10 or DAP12. DAP10 contains a YINM motif, through which p85a is recruited.
10 DAP12 recruits Syk/ ZAP70 and activates PLCg2. 12 However, the role of p85a has not been elucidated in any of these pathways. In the absence of DAP10, the NKG2D/DAP12 pathway has been suggested to compensate. 65 However, we found a significant reduction in the overall ability of p85a À/À NK cells to lyze target cells, indicating that NKG2D/DAP12 does not fully compensate for the impaired NKG2D/ DAP10 pathway. Thus, we conclude that NKG2D/ DAP12 pathway may also partially depend on PI3K to mediate cytotoxicity. Support for this comes from earlier studies, where Syk has been demonstrated to activate and regulate PI3K-mediated degranulations. 42 Although missing-self recognition does not utilize NKG2D/DAP10 complexes, our results demonstrate that p85a is required for the cytotoxicity against RMA/S cells. Further studies are needed to distinguish between 'impaired signaling' and 'hyporesponsiveness' of NK cells.
NK cells bridge innate and adaptive immune responses through the secretion of a variety of cytokines and chemokines. 66 Previous studies demonstrated that the lack of DAP12, or Syk/ZAP70 but not DAP10, severely impaired NKG2D-mediated cytokine production. 13, 65, 67 In contrast, a significant reduction in cytokine and chemokine generation was observed in p85a À/À NK cells, when activated through NKG2D. Similar reductions were also observed when p85a À/À NK cells were activated by NK1.1 receptor that signals through FcRg. 16 Our earlier studies have shown that combinations of PMA and Iono were required for the generation of IFN-g from NK cells. 28 However, this combination failed to p85a regulates cytokine generation in NK cells A Awasthi et al rescue IFN-g generation in p85a
À/À NK cells. One possible explanation for this observation is the existence of potential requirement of Src kinases that are activated by PMA. In fact, earlier studies have shown that PMA was unable to induce colocalization or activation of cSrc in cells that lacked the p85a and -b. 43 Thus, additional defects in p85a À/À NK cells may account for their failure to generate IFN-g. Together, we conclude that p85a is important in the cytokine generation by NK cells. Our results are consistent with recent observations using gene knockout mice for catalytic subunits of PI3K, p110g and p110d, where the NK-mediated cytotoxicity and cytokine generations were impaired. 68, 69 Reductions in the ability of p85a À/À NK cells in generating inflammatory cytokines need further explanations. Multiple mechanistic models can explain our findings (Figure 7 ). Recent studies in NK and other cell types have indicated potential cross talks between PI3K and PLCg2 pathways. 70, 71 Leibson laboratory has shown that binding of PI3K-p85 along with Grb2-Vav1 complexes was necessary for full calcium release and cytotoxicity.
70 NKG2D/DAP10 complexes can recruit combinations of p85a and Grb2 molecules, both of which bind to DAP10 by the YINM motif. Further, in this model, coupling of Grb2 complexes to DAP10 was necessary and sufficient for the recruitment and activation of Vav1, SLP76 and PLCg2. 70 This observation explains how NKG2D, without using adaptors such as LAT can effectively recruit PLCg2 leading to cytotoxicity. However, this study does not explain how the upstream events initiated from NKG2D/DAP10/p85 regulate cytokine generation. Our recent study has shown that the Carma1/Bcl10/Malt-1/NF-kB signaling axis is critical for NKG2D-mediated generation of cytokines. 72 DAG, generated by PLCg2 regulates Carma1 activation by PKC. 73 Thus, we predict DAP10/p85a/Grb2-Vav1 complexes can connect to Carma1/Bcl10/Malt-1/NF-kB axis by DAG and PKC.
In the second model (Figure 7) , we predict P13K can activate PLCg2 using Tec family PTKs such as Btk as described in B cells. 26 Phosphorylated Btk is recruited to the plasma membrane and binds to PI3K product, PtdIns-3,4,5-P 3.
74
Using this product, Btk generates PtdIns-4,5-P 2 , which is hydrolyzed by PLCg2 into DAG and IP 3. 75 DAG can activate PKCy; thus connecting the PI3K/Btk/PtdIns-3,4,5-P 3 pathway to Carma1/Bcl10/ Malt-1/NF-kB signaling axis. 76 In addition, PLCg2 may also regulate cytokine gene transcriptions through the production of IP 3 /Ca 2 þ /NFAT axis. Although the expression of Btk is primarily restricted to B cells, 26 its presence and function has yet to be explored in NK cells.
Further work is needed to analyze Btk or similar kinases that belong to Tec family in NK cells.
In the third model, we propose the involvement of PDK1 in cytokine generation ( Figure 7 ). PI3K activates PDK1, which phosphorylates PKCy. Activated PKCy can directly recruit IKK complexes into the lipid rafts. 71 PDK1 has also been shown to recruit Carma1/Bcl10/ Malt-1 complex or the membrane-bound Bcl10 to activate IKK. 71 Our recent studies showed NK cells from Tec Family Kinases PLC-γ2 Figure 7 Signaling pathways that are potentially regulated by p85a in the generation of cytokines. We propose that p85a can regulate cytokine gene transcriptions by: (1) a direct recruitment of PLCg2 by Grb2/Vav-1 complexes. Grb2 is an adapter protein that binds to DAP10 through the YINM motif. Activation and recruitment of Grb2 to NKG2D/DAP10 complexes has been shown to initiate phosphorylation of PLCg2. 70 PLCg is one of the major regulators of protein kinase C (PKC) by DAG. Thus, DAP10/p85a/Grb2-Vav1 complexes can signal either through Carma1/Bcl10/Malt-1/nuclear factor (NF)-kB or PLCg2/IP3/Ca 2 þ /NFAT, which lead to cytokine gene transcriptions. (2) Activation of PLCg2 by phosphotidylinositol-3-kinase (PI3K) by Tec kinases. Btk is a Tec family protein tyrosine kinase, which can bind to PI3K product, PtdIns-3,4,5-P 3 leading to the recruitment and phosphorylation of PLCg2. 26 This in turn can also result in the activation of PKC and Carma1/ Bcl10/Malt-1/NF-kB or PLCg2/IP 3 /Ca 2 þ /NFAT signaling pathways. (3) Direct link between PI3K and Carma1/Bcl10/Malt-1/NF-kB signaling axis. Recent studies have shown that PI3K-dependent kinase, PDK1, has the ability to activate PKC. 71 Thus, the activation of PKC can link the Carma1/Bcl10/Malt-1/NF-kB signaling axis to PI3K.
Bcl10
À/À72 or Carma1 À/À mice (H Chu and S Malarkannan, unpublished) also had severe impairment in generating cytokines in response to NKG2D-mediated activations. These studies provide support to our notion that both Carma1 and Bcl10 are obligatory signaling molecules, irrespective of PI3K-Btk-PLCg2 or PI3K-PDK1-PKCy-mediated cytokine generations. In conclusion, our current observations establish a strong basis to further explore PI3K-mediated cytokine generation in NK cells.
Materials and methods
Mice and cell lines PI3K-p85a
and WT mice were previously described. 20, 27 All mice used in this study were maintained in pathogen-free conditions at the Biological Resource Center (BRC), Medical College of Wisconsin (MCW), Milwaukee, WI, USA. All the animal protocols used were approved by the BRC, MCW, Milwaukee, WI, USA. EL4, EL4
H60 , RMA/S and YAC-1 cells and their culture conditions were described. 77 Fetal liver cell transplantation PI3K-p85a -/-mice were originally generated by transfecting mouse embryonic stem cell line TC-1 (129Sv) with targeting constructs and clones identified to contain the heterozygous gene disruption was injected into C57BL/6 blastocysts. 20 Chimeric male mice were bred with C57BL/6 mice. At the time of usage, original 129Sv lines were backcrossed to C57BL/6 to a minimum of seven generations. As less than 5% of the homozygous genedeleted newborns survive beyond 7 days of age, both WT and the p85a -/-were generated by crossing p85a þ /-Â p85a þ /-. Irradiated JAK3 -/-recipients (300 rad; 4-to 6-week old) of C57BL/6 background (H-2 b ) were transplanted with 2 Â 10 6 nucleated fetal liver cells from 13-to 14-day-old embryos of WT or p85a -/-through retroorbital injections. 27 After 2-3 months, development and functions of NK cells from BM, spleen and liver of the transplanted mice were examined (Figure 1a) . Reconstituted JAK3 -/-mice appeared normal without any external symptoms of any autoimmune pathology that has been previously reported in JAK3 -/-mice. 29, 30 Wherever indicated, WT and p85a -/-represent JAK3 -/-mice reconstituted with liver cells from p85a þ / þ or p85a -/-fetuses, respectively. All the mice used in this study were of H-2 b haplotype (data not shown).
Flow cytometry and cell sorting
Cell preparations were stained with fluorescent-labeled mAbs as described. 77 Abs for NK1.1 (PK136), CD3e (145-2C11), NKG2D (A10), NKG2A/C/E (20d5), CD11b (M1/70), CD43 (1B11), CD49b (DX5), CD51 (RMV-7), CD122 (5H4) and Ly49I (YLI-90) were obtained from e-Bioscience (San Diego, CA, USA). Abs for Ly49A (A1), Ly49C/I (5E6), Ly49D (4E5) and Ly49G2 (4D11) were obtained from BD Biosciences (San Jose, CA, USA). Standard flow cytometry analyses were carried out in LSR-II using FACSDiva software (Becton Dickinson, Franklin Lakes, NJ, USA). Splenocytes from WT mice were stained with anti-CD3e, -B220 or -NK1.1 mAbs and subjected to cell sorting using FACSAria (Becton Dickinson) to isolate T, B and NK cells, respectively.
Western blotting
Immunoblots of p85a in T, B and NK cell lysates were performed as previously described. 27 Whole-cell lysates (40 mg) were resolved using 12% SDS-polyacrylamide gel electrophoresis (PAGE) gels and transferred to nitrocellulose membranes and probed with indicated Abs. Antimouse p85a (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and anti-b-Actin (Boehringer Mannheim, Germany) antibodies were used and signals were detected using ECL kit (GE Healthcare, Piscataway, NJ, USA).
NK cell preparation NK cells were purified as previously described. 72 Briefly, single-cell suspensions from spleen and BM were passed through nylon wool columns to deplete adherent populations consisting of B cell and macrophages. Nylon wool nonadherent cells were cultured with 1000 U ml À1 of IL-2 (NCI-BRB-Preclinical Repository, Maryland, MD, USA). Nonadherent cells were removed on days 4, 5 and 6 and the remaining adherent cells were replenished with IL-2-containing medium to generate highly enriched NK cells. NK cell preparations were tested for purity and all experiments were carried out using 6-or 7-day-old NK cells. NK preparations with more than 90% of NK1.1 þ cells were used (Supplementary Figure 1 ).
Cytotoxicity assays NK-mediated cytotoxicity was quantified using 51 Chromium ( 51 Cr)-labeled target cells at varied Effector to Target ratio (E:T Ratio). Percent-specific lysis was calculated using amounts of absolute, spontaneous and experimental 51 Cr-release from target cells. Briefly, IL-2-cultured NK cells on day 6 or 7 were incubated with target cells for 4 h at 37 1C and the percent cytotoxicity was assayed by quantifying the amount of 51 Cr released into the supernatant.
Secretion and quantification of cytokines and chemokines through ELISA and Bioplex assays IL-2-cultured, NK cells on day 6 were harvested, Fc-blocked and were activated with titrated concentrations of plate-bound anti-NKG2D (A10) or -NK1.1 (PK136) mAbs. Nunc Immunolon plates were coated with varying concentration of mAbs for overnight, washed thrice with phosphate-buffered saline before the addition of NK cells. Culture supernatants were collected between 16 and 18 h and used for cytokine and chemokine quantification. Standard curves generated using recombinant cytokines were used to calculate the concentrations of IFN-g and GM-CSF in the culture supernatants using ELISA kits (eBioscience, San Diego, CA, USA). MIP-1a and MIP-1b were quantified using Bioplex kits (Bio-Rad, Richmond, CA, USA).
Drug inhibition assays IL-2-activated NK cells (sixth day) were Fc-blocked and treated with pharmacological inhibitors for PI3K (Wortmannin; Sigma-Aldrich, St Louis, MO, USA) and Syk (Piceatannol; AG scientific Co., San Diego, CA, USA) separately or in combination for 1 h at room temperature. Treated cells were washed twice and used in cytotoxicity or cytokine assays as described. 72 Cytotoxicity was performed against EL4 H60 at 20:1 E:T ratio. For cytokine generation, treated and untreated cells were added to p85a regulates cytokine generation in NK cells A Awasthi et al Nunc Immunolon plates that were precoated with 5 mg ml À1 of anti-NKG2D (A10) mAb. Culture supernatants were collected between 16 and 18 h and assayed for IFN-g through ELISA.
Statistical analysis Statistical analysis was performed by two-tailed, paired, Student's t-test using Microsoft Excel 2003 software to compare the differences between WT and p85a -/-mice. P-values of o0.05 were considered significant.
